Paper25887482
Gene-expression molecular subtyping of triple-negative breast cancer tumours: importance of immune response.
Jézéquel P and 10 others. Breast Cancer Res, 2015. Cited by 252 papers, by iCite.
Cite this record
ConductScience Library. Gene-expression molecular subtyping of triple-negative breast cancer tumours: importance of immune response. Papers, record 25887482. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25887482
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Gene-expression molecular subtyping of triple-negative breast cancer tumours: importance of immune response.
- PubMed
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Gene Expression Profiling | Major topic |
| Gene Expression Regulation, Neoplastic | Major topic |
| Triple Negative Breast Neoplasms | Major topic |
| Adult | |
| Aged | |
| Biomarkers, Tumor | |
| Cluster Analysis | |
| Computational Biology | |
| Female | |
| Humans | |
| Immunity, Innate | |
| Immunohistochemistry | |
| Kaplan-Meier Estimate | |
| Middle Aged | |
| Molecular Sequence Annotation | |
| Neoplasm Staging | |
| Prognosis | |
| Reproducibility of Results | |
| Retrospective Studies | |
| Transcriptome | |
| Tumor Burden |
Source PubMed
References54
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22220191 | Homogeneous datasets of triple negative breast cancers enable the identification of novel prognostic and predictive signatures. | PLoS One | 2011 | https://conductscience.org/library/papers/22220191 | PubMed |
| 2 | 19188147 | The macrophage colony-stimulating factor 1 response signature in breast carcinoma. | Clin Cancer Res | 2009 | https://conductscience.org/library/papers/19188147 | PubMed |
| 3 | 18438415 | Stromal gene expression predicts clinical outcome in breast cancer. | Nat Med | 2008 | https://conductscience.org/library/papers/18438415 | PubMed |
| 4 | 24202395 | Microenvironmental regulation of tumor progression and metastasis. | Nat Med | 2013 | https://conductscience.org/library/papers/24202395 | PubMed |
| 5 | 25214542 | The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014. | Ann Oncol | 2015 | https://conductscience.org/library/papers/25214542 | PubMed |
| 6 | 20080943 | IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion. | Genes Dev | 2010 | https://conductscience.org/library/papers/20080943 | PubMed |
| 7 | 21633166 | Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. | J Clin Invest | 2011 | https://conductscience.org/library/papers/21633166 | PubMed |
| 8 | 17493263 | Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. | Genome Biol | 2007 | https://conductscience.org/library/papers/17493263 | PubMed |
| 9 | 21067385 | Triple-negative breast cancer. | N Engl J Med | 2010 | https://conductscience.org/library/papers/21067385 | PubMed |
| 10 | 22110708 | Down-regulation of ECRG4, a candidate tumor suppressor gene, in human breast cancer. | PLoS One | 2011 | https://conductscience.org/library/papers/22110708 | PubMed |
| 11 | 19192299 | GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists. | BMC Bioinformatics | 2009 | https://conductscience.org/library/papers/19192299 | PubMed |
| 12 | 15328174 | Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. | Clin Cancer Res | 2004 | https://conductscience.org/library/papers/15328174 | PubMed |
| 13 | 19204204 | Supervised risk predictor of breast cancer based on intrinsic subtypes. | J Clin Oncol | 2009 | https://conductscience.org/library/papers/19204204 | PubMed |
| 14 | 10963602 | Molecular portraits of human breast tumours. | Nature | 2000 | https://conductscience.org/library/papers/10963602 | PubMed |
| 15 | 23404817 | Molecular characterization of basal-like and non-basal-like triple-negative breast cancer. | Oncologist | 2013 | https://conductscience.org/library/papers/23404817 | PubMed |
| 16 | 19465376 | ToppGene Suite for gene list enrichment analysis and candidate gene prioritization. | Nucleic Acids Res | 2009 | https://conductscience.org/library/papers/19465376 | PubMed |
| 17 | 23948975 | Differential response to neoadjuvant chemotherapy among 7 triple-negative breast cancer molecular subtypes. | Clin Cancer Res | 2013 | https://conductscience.org/library/papers/23948975 | PubMed |
| 18 | 19568420 | Deconvolution of blood microarray data identifies cellular activation patterns in systemic lupus erythematosus. | PLoS One | 2009 | https://conductscience.org/library/papers/19568420 | PubMed |
| 19 | 19033363 | Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. | Nucleic Acids Res | 2009 | https://conductscience.org/library/papers/19033363 | PubMed |
| 20 | 17683518 | An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer. | Genome Biol | 2007 | https://conductscience.org/library/papers/17683518 | PubMed |
Cited by196
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 252 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42941844 | Serum Proteomic Profiling by SomaScan Aptamer Array Identifies Candidate Predictive and Monitoring Biomarkers of Distant Recurrence in Triple-Negative Breast Cancer. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42941844 | PubMed |
| 42291245 | Tumor-infiltrating lymphocytes display prognostic signatures associated with chemotherapy response in TNBC patients. | iScience | 2026 | https://conductscience.org/library/papers/42291245 | PubMed |
| 42270806 | Integrative single-cell and spatial transcriptomics with machine learning identify a Luminal-inflam malignant program and reveal an RPN1-PERK UPR vulnerability in triple-negative breast cancer. | Sci Rep | 2026 | https://conductscience.org/library/papers/42270806 | PubMed |
| 42258564 | Integrated Analysis Identifies an Anoikis-Related Gene Signature for Predicting Prognosis in Patients With Triple-Negative Breast Cancer. | IET Syst Biol | 2026 | https://conductscience.org/library/papers/42258564 | PubMed |
| 42193932 | The Organoid Decade: Leveraging 3D Patient-Derived Organoids to Bridge the Translational Gap in Triple-Negative Breast Cancer: A Systematic Review. | Cells | 2026 | https://conductscience.org/library/papers/42193932 | PubMed |
| 42099633 | Multi-omics analysis of ST3GAL4-mediated lacto/neolacto glycosphingolipid metabolism reveals immune evasion and poor prognosis in TNBC. | Front Immunol | 2026 | https://conductscience.org/library/papers/42099633 | PubMed |
| 42095097 | Endothelial-derived PANoptosis factor IL33 is a potential immunotherapy in breast cancer. | iScience | 2026 | https://conductscience.org/library/papers/42095097 | PubMed |
| 42057887 | Identification of a prognostic model using immune related genes combined with tumour mutational burden and T cell infiltration in triple-negative breast cancer. | Oncol Lett | 2026 | https://conductscience.org/library/papers/42057887 | PubMed |
| 42027644 | Machine learning-based programmed cell death gene signature for prognosis and drug sensitivity in breast cancer. | Oncol Lett | 2026 | https://conductscience.org/library/papers/42027644 | PubMed |
| 41876831 | TRIM21-mediated degradation of HILPDA overcomes anti-PD-1 immunotherapy resistance in breast cancer by limiting PD-L1 palmitoylation. | Oncogene | 2026 | https://conductscience.org/library/papers/41876831 | PubMed |
| 41771848 | A Lamp2a-linked RNA secreted by ADSCs prevents ENO1-lactylation-glycolysis feedback and cell malignant behavior in triple-negative breast cancer. | Cell Death Dis | 2026 | https://conductscience.org/library/papers/41771848 | PubMed |
| 41511527 | CA9+ cancer-associated fibroblasts cooperate with SPP1+ tumor-associated macrophages driving immune resistance in triple-negative breast cancer. | Cell Mol Life Sci | 2026 | https://conductscience.org/library/papers/41511527 | PubMed |
| 41162433 | Implication of an exosome-based gene signature for estimating clinical outcomes of triple-negative breast cancer and assisting in individualized therapy. | Sci Rep | 2025 | https://conductscience.org/library/papers/41162433 | PubMed |
| 40792137 | Development and validation of a Hypoxia and Lactate Metabolism Prognostic Score (HLMPS) for breast cancer using machine learning. | Transl Cancer Res | 2025 | https://conductscience.org/library/papers/40792137 | PubMed |
| 40746884 | Identification of Molecular Subtypes and Prognostic Features for Triple-Negative Breast Cancer Based on Golgi Apparatus-Related Gene Signature. | Oncol Res | 2025 | https://conductscience.org/library/papers/40746884 | PubMed |
| 40531994 | FAM50A drives breast cancer brain metastasis through interaction with C9ORF78 to enhance ʟ-asparagine production. | Sci Adv | 2025 | https://conductscience.org/library/papers/40531994 | PubMed |
| 40524231 | Multi-omics analyses of the heterogenous immune microenvironment in triple-negative breast cancer implicate UQCRFS1 potentiates tumor progression. | Exp Hematol Oncol | 2025 | https://conductscience.org/library/papers/40524231 | PubMed |
| 40340806 | Transcriptome-wide analysis reveals potential roles of CFD and ANGPTL4 in fibroblasts regulating B cell lineage for extracellular matrix-driven clustering and novel avenues for immunotherapy in breast cancer. | Mol Med | 2025 | https://conductscience.org/library/papers/40340806 | PubMed |
| 40329944 | Heterogeneity of anoikis in triple-negative breast cancer subtyping and therapeutic implications. | Genes Dis | 2025 | https://conductscience.org/library/papers/40329944 | PubMed |
| 40314763 | Metabolomics as a tool for understanding and treating triple-negative breast cancer. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | https://conductscience.org/library/papers/40314763 | PubMed |
Genes43
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/25887482
GET https://conductscience.org/api/papers/v1/25887482/references?page=2